Centric Health Corp. (TSE:CRX – Get Rating) – Research analysts at Desjardins lowered their FY2024 EPS estimates for shares of Centric Health in a report released on Thursday, March 2nd. Desjardins analyst G. Ho now forecasts that the company will post earnings per share of $0.09 for the year, down from their previous estimate of $0.14.
Separately, Bloom Burton reaffirmed a “buy” rating on shares of Centric Health in a report on Tuesday, December 6th.
Centric Health Price Performance
See Also
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
- Taiwan Semiconductor Manufacturing Expanding in the West
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
